Today: 7 February 2026
Subscribe
Browse Category

NYSE:MANU News 9 December 2025 - 11 December 2025

Manchester United (MANU) Stock After Q1 2026 Earnings: Debt Surge, Stadium Dreams and 40%+ Upside Targets

Manchester United (MANU) Stock After Q1 2026 Earnings: Debt Surge, Stadium Dreams and 40%+ Upside Targets

Manchester United’s New York–listed shares (NYSE: MANU) closed at $15.78 on 11 December 2025, up 2.5% on the day after a volatile session that saw the stock trade between $14.86 and $16.11 and leaves the club down about 10.6% over the past year.Investing.com That price values the club at roughly $2.7–2.8 billion, a significant premium to most football peers but below the levels seen during takeover speculation in 2023–24. The move came as investors digested first‑quarter fiscal 2026 results, a deepening debt pile of around £1.29 billion, and management’s reaffirmed guidance – plus a surprisingly optimistic set of analyst price targets that still imply 40–50% upside from
11 December 2025
··
Wolves vs Man United 4–1 Result: Fernandes Brace, Wolves Protests and What It Means for Manchester United Stock (NYSE: MANU)

Wolves vs Man United 4–1 Result: Fernandes Brace, Wolves Protests and What It Means for Manchester United Stock (NYSE: MANU)

Manchester United enjoyed a powerful start to the week on Monday, 8 December 2025, dismantling Wolverhampton Wanderers 4–1 at Molineux to rise to sixth in the Premier League table and extend their unbeaten away run to five league matches. Bruno Fernandes scored twice, with Bryan Mbeumo and Mason Mount also on the scoresheet, as Wolves’ dismal form and fan unrest deepened. Premier League+1 Across the Atlantic, Manchester United’s Class A shares (NYSE: MANU) are still stuck in the mid‑$15 range, giving the club a market capitalisation of roughly $2.7 billion and leaving the stock about 9–10% lower over the past 12 months as of the close on 8 December 2025, despite
9 December 2025
·

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop